drugset / Trial / NCT00151996
Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of administering SPD503 (Guanfacine hydrochloride) with psychostimulants (amphetamine or methylphenidate) for treatment of ADHD in children and adolescents aged 6-17
Timeline
- Start
- 2004-08-16
- Primary completion
- 2004-12-27
- Completion
- 2004-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guanfacine | Small molecule | 1 mg | — |
| Subject | Guanfacine | Small molecule | 2 mg | — |
| Subject | Guanfacine | Small molecule | 3 mg | — |
| Subject | Guanfacine | Small molecule | 4 mg | — |
| Background | Amphetamine | Unknown | — | — |
| Background | Methylphenidate | Small molecule | — | — |